Clinical Laserthermia Systems AB (publ) (CLS-B.ST)
Clinical Laserthermia Systems AB (publ) operates in the Medical - Specialties industry of the Healthcare sector, headquartered in Lund, SN, SE. The stock last traded at $1.79, down 0.99% on the session, giving a market capitalisation of $56.4M. Its beta of -0.09 implies it has historically moved less than the broad market.
Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. It offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. The company also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers that provides multiple options to control treatment. In addition, it offers various gauge laser applicators and introducers, as well as provides temperature and treatment monitoring devices. Clinical Laserthermia Systems AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.
Clinical Laserthermia Systems AB (publ) is most often compared with the following Healthcare names: